Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2014 06:55 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Acquire Lumara Health Maternal Health Business

Accelerates transformation of AMAG to a Profitable, Multi-Product Specialty Pharmaceutical Company Adds FDA-Approved Therapy Makena® and Complementary Commercial Platform to AMAG...
September 16, 2014 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Judith Johnson, M.D. as Vice President of Pharmacovigilance and Pharmacoepidemiology

WALTHAM, Mass., Sept. 16, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that Judith Johnson, M.D., has rejoined the company as vice president of pharmacovigilance...
September 08, 2014 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors

WALTHAM, Mass., Sept. 8, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that John Fallon, M.D., senior vice president and chief physician executive at Blue Cross...
August 29, 2014 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences

WALTHAM, Mass., Aug. 29, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that company management will discuss AMAG's business and financial outlook, strategy and...
August 12, 2014 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer

WALTHAM, Mass., Aug. 12, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced the appointment of Robert Blood, Esq. as vice president of legal affairs and chief compliance...
August 01, 2014 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. to Participate in Jefferies Boston Healthcare Summit

WALTHAM, Mass., Aug. 1, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that Frank Thomas, chief operating officer, and Scott Holmes, senior vice president of finance...
July 29, 2014 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Second Quarter and Six Month 2014 Financial Results and Updates Financial Guidance for 2014

Record Physician Demand Drives 27% Increase in U.S. Net Feraheme Revenues Strong Sales Growth and Disciplined Expense Management Generate Positive Operating Income Conference call scheduled for...
July 25, 2014 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals, Inc. to Host Conference Call on July 29, 2014 at 8:00 a.m. ET to Discuss Financial Results for the Quarter and Six Months Ended June 30, 2014

LEXINGTON, Mass., July 25, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced it will report unaudited consolidated financial results for the quarter and six months...
June 11, 2014 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Appoints Melissa Bradford Klug as Senior Vice President of Business Development and Strategy

WALTHAM, Mass., June 11, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced the appointment of Melissa Bradford Klug as senior vice president of business development and...
June 06, 2014 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Patent Term Extension for Ferumoxytol in the U.S.

WALTHAM, Mass., June 6, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that the United States Patent and Trademark Office (USPTO) has issued a U.S. patent term...